Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.

Robert J RothrockAhmad OzairMaria C AvendanoSusana HerreraHaley AppelSuyen RamosAmy K StarosciakDaniel S Leon-ArizaMuni RubensMichael W McDermottManmeet S AhluwaliaMinesh P MehtaRupesh R Kotecha

Published in: Trials (2024)

Version 2.0 of the protocol (2021-KOT-002), revised last on September 2, 2022, was approved by the WCG institutional review board (Study Number 1337188, IRB tracking number 20223735). The trial was first posted on ClinicalTrials.Gov on September 9, 2022 (NCT05534321). Patient enrollment commenced on August 19, 2022, and is expected to be completed in 2 years, likely by August 2024.

Keyphrases

randomized controlled trial
clinical trial
early stage
spinal cord
study protocol
case report
spinal cord injury
rectal cancer
open label